GL GLOBE LIFE INC. Insider Trading

EVP & CFO Thomas Peter Kalmbach sold 7,936 shares of GL at $156.59 on 2026-05-22, reducing holdings to 50,495 shares; 5 prior GL sells all posted negative 90d returns.

On 2026-05-22, Thomas Peter Kalmbach (EVP & CFO) sold 7,936 shares at $156.59, reducing his holdings by -13.6% to 50,495 shares. The stock is trading near its 52-week high of $157.92 at current price $156.70, up 8.7% over 90 days. Notably, across Kalmbach's 5 prior sales at GL, all posted negative 90-day returns (ranging from -1.4% to -2.8%), with a 90-day well-timed rate of 100% at this ticker. His cross-ticker track record on 8 prior sells shows an average 90-day return of -3.2% with a 100% well-timed rate. The company has solid fundamentals: $1.6B in latest-quarter revenue, $270.5M net income, and a P/E of 10.34. The question for investors is whether this sale—given the consistent negative post-sale price movements in Kalmbach's prior GL transactions—represents another instance of the pattern, or a break from it in a market that has recently rallied.

Frank M Svoboda sold 20,000 shares at blended avg $156.68 for $3.1M; post-sale holdings 54,020 shares (-27.0% reduction).

Frank M Svoboda, who was Co-Chairman & CEO of Globe Life Inc., executed 2 separate sales totaling 20,000 shares for $3,133,587.54 at prices ranging from $156.65 to $157.05 on 2026-05-22, reducing his stake from 74,020 to 54,020 shares. The sales occurred at prices very close to the 52-week high of $157.92 (current price $156.70 is -0.8% from that peak), and the stock has risen +2.7% in the prior 30 days and +8.7% in the prior 90 days. His prior 5 trades at this ticker all resulted in subsequent positive returns at the 90-day mark (ranging from +1.3% to +1.8%), with 0 of 5 classified as well-timed on that metric, suggesting his recent sell pattern at this ticker has not preceded material declines. The company trades at a P/E of 10.34 with stable fundamentals (revenue $1,559,619,000.00, net income $270,526,000.00, annual revenue growth +3.7%), indicating no obvious fundamental distress signal.

CFO Kalmbach sold 11,903 shares of GL at $156.61 for $1.9M; 5 of 5 prior GL sales were well-timed with negative 90d returns.

Thomas Peter Kalmbach, EVP & CFO, sold 11,903 shares at $156.61 on 2026-05-19, reducing his holdings by 19.7% from 60,334 to 48,431 shares. His prior trading pattern at GL is notable: all 5 previous sales were well-timed at the 90-day mark, each followed by stock declines ranging from -1.4% to -2.8% over 90 days. The current sale price of $156.61 is -2.4% from the 52-week high of $157.92, placing it near but slightly below recent peaks. GL trades at a P/E of 10.16 with $1.6B in latest quarterly revenue and a $12.0B market cap, fundamentals that provide context for evaluating the signal. Investors should monitor whether this sale follows the established pattern of his prior GL trades or represents a departure from his timing accuracy at this ticker.

Globe Life CFO Kalmbach acquires 35,000 shares net while selling 27,427; mixed-timing insider with strong 90-day track record but conflicting short-term signals.

Kalmbach, the company's Chief Financial Officer, executed a complex two-day set of transactions on May 8–11 that netted an acquisition of 35,000 shares, making this his first open-market purchase in the three-year filing window. The trade is notable because it occurs in a company with solid fundamentals—profitable with modest revenue growth—and the stock trades very near its 52-week high. Kalmbach's prior trading record at this ticker is mixed: his four earlier sales have all proven well-timed as the stock declined after each exit, yet his one prior purchase showed poor timing with shares falling in the following month before recovering over a longer period. The current transaction's unusual structure—simultaneous buying and selling across two days—suggests active rebalancing rather than conviction-based accumulation, and the fact that he sold nearly as many shares as he acquired complicates the bullish signal that a pure acquisition might otherwise send.

CEO Frank Svoboda executes large sale near 52-week highs while maintaining buy activity, signaling selective profit-taking.

Frank Svoboda, Globe Life's Co-Chairman and CEO, executed a complex transaction pattern on consecutive days that reveals selective profit-taking rather than wholesale portfolio reduction. Despite a net outflow of over $2.3 million in sales, Svoboda simultaneously made material purchases, suggesting he is pruning positions that have appreciated while maintaining conviction in the company. The stock is currently trading near its 52-week high and has appreciated meaningfully over the past quarter — a classic setup for insider profit-taking without abandonment. Historically, Svoboda's prior sales in this stock preceded periods where the stock either fell or remained flat, making his timing track record reasonably reliable. The underlying company remains fundamentally sound and profitable, indicating Svoboda is not panicking but rather making deliberate rebalancing decisions at an attractive price level.

Globe Life Co-Chairman & CEO Darden buys $2.2M shares while simultaneously selling $3.4M stake, net reduction.

Darden James Matthew, the Co-Chairman and CEO of Globe Life, executed a mixed trade on a single day: purchasing approximately 22,000 shares while selling roughly 22,000 shares across two transactions, netting a reduction in his overall position. The purchase price on the buy side was substantially lower than the sale prices, suggesting some tactical repositioning rather than conviction buying—he's trimming an existing stake at elevated levels while redeploying a portion into a lower entry point. Globe Life is a profitable company with steady revenue and a conservative valuation, which provides a reasonable backstop for his existing holdings. However, Darden's pattern of primarily selling (12 prior sells versus only 2 buys in his track record) and five recent GL sells dating back months signal a consistent trimming bias that reflects portfolio management rather than emerging insider confidence in a turnaround or material positive catalyst.

Co-Chairman and CEO Frank Svoboda exercises and immediately sells equal-sized blocks, netting $530k gain while stock trades near 52-week highs.

Frank Svoboda, Globe Life's Co-Chairman and CEO, exercised 10,000 shares and sold 10,000 shares in the same transaction date, creating a net-zero change in his position. This is a classic equity exercise-and-sell pattern — compensation vesting followed by immediate liquidation — rather than a reflection of insider conviction about the stock's direction. The sales occurred as the stock trades near its 52-week highs, a common window for executives to realize value from vested equity without signaling concerns about future performance. Svoboda's prior Form 4 activity over the past three years shows 23 prior open-market sales against only 2 purchases, establishing a strong seller-oriented pattern. At the ticker level, his five prior sells at Globe Life show mixed timing results — three were well-timed exits (the stock fell after those sales) while two were poorly timed (the stock rose afterward) — indicating inconsistent success reading this specific company's near-term direction. Against a backdrop of solid company fundamentals—profitable operations with modest revenue growth and reasonable valuation—this transaction reads as routine equity management rather than a directional bet.

C-suite executive executes large purchase of GL shares amid mixed signals—substantial buy paired with simultaneous heavy selling.

A senior executive at Globe Life purchased over 34,000 shares while concurrently divesting more than 34,000 shares, netting approximately $5.2 million in proceeds. The simultaneous buy and sell pattern suggests portfolio rebalancing or liquidity management rather than a pure conviction buy, which tempers the bullish signal typically associated with insider accumulation. Globe Life is a profitable, fundamentally sound company with reasonable valuation and steady revenue growth, but the executive's decision to sell nearly as much as purchased raises questions about near-term confidence. The stock is trading near its all-time highs for the period, meaning the insider is not buying weakness but rather maintaining exposure at elevated levels. This mixed positioning—combining disciplined buying with hedging sales—warrants closer inspection of the timing and the executive's historical trading behavior to determine whether this reflects genuine confidence or prudent risk management.